İbrahim DEMİRKAN, İsa ÖZAYDIN, Gültekin ATALAN, Halil İbrahim GÖKÇE, Fikret ÇELEBİ

Köpekler de butorphanol-ketamin HCI kombinasyonunun ksilazin-ketamin HCI kombinasyonuyla klinik ve kardiyovasküler/pulmoner etkileri yönünden karşılaştırılması

The cardiovascular/respiratory and clinical effects of a xylazine-ketamine combination or a butorphanol-ketamine combination for the induction of anaesthesia in dogs were compared. A total of 12 dogs (two groups 6 dogs each) were premedicated with either xylazine (group I) or butorphanol (group II) and anaesthetized with ketamine HCl and monitored at 0, 5, 15, 30 and 60 min after induction. Sedative effects in both groups started within 15 min. Respiratory rate was significantly decreased in group I (P < 0.05). Body temperature was significantly altered after 15 min in group I (P < 0.05 and P < 0.001). Haematological analyses indicated that there were no differences in pH values between the groups. It was concluded that butorphanol followed by ketamine was comparable with xylazine plus ketamine for the induction of anaesthesia in healthy dogs.

Comparative study of butorphanol-ketamin HCI and xylazine-ketamin HCI combinations for their clinical and cardiovasclar/respiratory efects in healthy dogs

PDF

___

1. Haskins, S.C., Patz, J.D., Farver, T.B.: Xylazine and xylazine–ketamine in dogs. Am. J. Vet. Res. 1986; 47: 636-641
2. Green, S.A., Thurman, J.C.: Xylazine – a review of its pharmacology and use in veterinary medicine. J. Vet. Pharma. Ther. 1981; 1: 295-313.
3. Klide, A.M., Calderwood, H.W., Soma, L.R.: Cardiopulmonary effects of xylazine in dogs. Am. J. Vet. Res. 1975; 36: 931-935.
4. Paddleford, R.R., Harvey, R.C.: Alpha-2 agonists and antagonists. Vet. Clin. North Am. Small Anim. Pract. 1999; 29: 737-745.
5. Gross, M.E., Tranquili, W.J., Thurmon, J.C.: Hemodynamic effects of IV midazolam-xylazine-butorphanol in dogs. Vet. Surg. 1990; 19: 173-180.
6. Hsu, W.H., Lu, Z.X., Hembrough, F.B.: Effect of xylazine on heart rate and arterial pressure in conscious dogs, as influenced by atropine, 4-aminopyridine, doxapram, and yohimbine. J. Am. Vet. Med. Assoc. 1985; 186: 153-156.
7. Klide, A.M., Calderwood, H.W., Soma, L.R.: Cardiopulmonary effects of xylazine in dogs. Am. J. Vet. Res. 1975; 36: 931-935.
8. Kroneberg, G., Oberdorf, H., Hoffmeister, F.: Zur pharmakologie von 2-(2,6-dimethylphenylamino)-4-H-5,6-dihydro-1,3-thiazen (Bayer 1470) eines hemmstoffes adrenergischer und cholinergischer neurone. Naunyn Schmiedebergs Arch Pharmocologie. 1967; 256: 257-280.
9. Pachter, I.J., Evens, R.P.: Butorphanol.: Drug Alcohol Depend. 1985; 14: 324-338.
10. Martin, W.R., Eades, C.C., Thompson, J.A., Huppler, R.E., Gilbert, P.E.: The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharma. & Exp. Thera. 1976: 197, 517.
11. Pascoe, P.J.: Opioid analgesics. Vet. Clin. North Am. Small Anim. Pract. 2000; 30: 757-772.
12. Tobin, T., Combie, J., Miller, J.R., Crimson, M.W., Blake, J.W.: Pharmacology of narcotic analjezic in the horse II. Studies on the detection, pharmacokinetics, urinary clearance times and behavioral effects of pentozocine and fentanyl in the horse, Irish Vet. J. 1979; 33 (10): 169-176.
13. Stoelting, R.K.: Nonbarbiturate induction drugs. In: Pharmacology and Physiology in Anaesthetic Practice. Philadelphia, Lippencott, Raven. pp 140-157. 1999.
14. Hall, L.W., Clarke, K.W.: Opioid analgesics. In: Veterinary Anaesthesia. Philadelphia, USA. 64-72, 1991. ISBN 0-70-20- 1421-4.
15. Hirota, K., Lambert, D.G.: Ketamine: its mechanism of action(s) and unusual clinical uses. Br. J. Anaesth. 1996; 77: 441-444.
16. Hui, T.W., Short, T.G., Hong, W., Suen, T., Gin, T., Plummer, J.: Additive interactions between propofol and ketamine when used for anaesthesia induction in female patients. Anaesthesiology. 1995; 82: 641-648.
17. Ilkjaer, S., Peterson, K.L., Brennum, J., Wernberg, M., Dahl, J.N.: Effects of systemic N-methyl-D-aspartate receptor antagonists (ketamine) on primary and secondary hyperalgesia in humans. Br. J. Anaesth. 1996; 76: 829-834.
18. Tranquili, W.J., Fikes, L.L., Raffe, M.R.: Selecting the right analgesics: Indications and dosage requirements. Vet. Med. 1989; 84: 692-697.
19. Robertson, J.T., Muir, W.W.: A new analgesic drug combination in the horse. Am. J. Vet. Res. 1983; 44: 1667-1669.
20. Kalpravidh, M., Lumb, W.V., Wright, M., Heath, R.B.: Effects of butorphanol, flunixin, levorphanol, morphine, and xylazine in ponies. Am. J. Vet. Res. 1985; 45: 217-223.
21. Pircio, A.W., Gylys, J.A., Cavanagh, R.L.: The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic, antagonist, analgesic. Arch. Int. Pharmadyn. Thera. 1976; 220: 231-256.